Cripps advises Eqwal Group on the acquisition of Limbtex Holdings, a UK based prosthetic and orthotic device materials and equipment manufacturer & distributor

Cripps’ corporate team has advised Eqwal Group, a global prosthetics and orthotics manufacturer and patient care services provider, on the acquisition of Limbtex Holdings.

Limbtex Holdings was incorporated by Mike Goodall, who recognised a gap in the market for the supply of high-quality materials used in the manufacturing & production of prostheses, orthoses & complementary equipment. Limbtex Holdings operates as a single-source destination for its B2B customer base, serving UK manufacturers and the NHS, as well as exporting both via dedicated distributors and direct to international manufacturers.

By acquiring Limbtex Holdings, Eqwal Group have continued their solid M&A track record.

The Cripps’ corporate team who advised on this transaction comprised Olivier Morel, Kate Sun, Abigail Kirk and Inez Abeynayake.

Commenting on the support provided, Paul Steeper of Eqwal UK said “The Cripps team gave consistent commercial advice and kept a cool head despite a tight deadline and several last-minute changes to the structure”.  Jean-Pierre Mahe, CEO and Chairman of Eqwal Group said “Because they specialise in Franco-British deals, I was very happy to rely on Cripps to advise us on matters of English law and help us analyse the risks involved in the acquisition. We very much look forward to working with Mike Goodall and Limbtex as a part of our group.”

For more information about how we can support your business, please contact a member of the corporate team.